Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 15, 2021 |
| Target | Prometic Bioproduction |
| Sector | Life Science |
| Buyer(s) | Kedrion |
| Sellers(s) | Liminal BioSciences |
| Deal Type | Divestiture |
FILTER BY
Kedrion is engaged in development, manufacture, and distribution of a broad range of protein products derived from human plasma. Kedrion was founded in 2001 and is based in Lucca, Italy.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| State: Quebec | 1 of 1 |
| Country: Canada | 1 of 1 |
| Year: 2021 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-04-07 |
Kedrion - U.S. Plasma Donation Centers
Wilmington, Delaware, United States Kedrion's U.S. Plasma Donation Centers provide plasma supply through organic and inorganic growth with immediate access to approximately 1.4 million liters per year and obtain approximately 240,000 liters per year. |
Sell | $55M |
| Category | Company |
|---|---|
| Founded | 1994 |
| Sector | Life Science |
| Employees | 251 |
| Revenue | 1M CAD (2021) |
Liminal BioSciences is a biopharmaceutical company with globally recognized expertise in bioseparations, plasma-derived therapeutics, and small-molecule drug development. The Company offers its state-of-the-art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics. Liminal BioSciences was founded in 1994 and is based in Laval, Canada.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| State: Quebec | 1 of 1 |
| Country: Canada | 1 of 1 |
| Year: 2021 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-08-24 |
Telesta Therapeutics
Saint-Laurent, Quebec, Canada Telesta Therapeutics, Inc. is a clinical stage biotechnology company focused on the development, manufacturing, and commercialization of proprietary and innovative therapeutics for the global human health market. The Company’s anchor product is in Phase III clinical development to treat non-muscle-invasive bladder cancer. |
Buy | - |
